Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Rotational autokeratoplasty for the treatment of patients with cornea disease and cataract

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Surgical Cornea

Session Date/Time: Saturday 10/09/2016 | 15:00-16:30

Paper Time: 16:10

Venue: Poster Village: Pod 3

First Author: : V.Naumenko RUSSIA

Co Author(s): :    M. Pravosudova              

Abstract Details

Purpose:

To evaluate biological, optical and refractive results of combined rotational autokeratoplasty and cataract surgery.

Setting:

: St.Petersburg Branch of S.N. Fyodorov IR&TC “Eye Microsurgery”, Russia.

Methods:

In our study we included 12 patients (12 eyes) at the age of 36-63 years. The all patents had leucoma I-II and cataract. The all ones underwent combined rotational autokeratoplasty and exstracapsular cataract extraction with intraocular lens implantation. We used 7 mm trephine for all cases. Before operation the visual acuity was not more than 0,05 with correction in all eyes. The mean astigmatism degree was 4,2±3,3 D. Cornea endothelium cells density in clear trephine zone was 1450±580 c/mm² at average. These patients were followed up for 5 years at average.

Results:

In the long-term follow-up the mean endothelium cell loss was 8%, the mean visual acuity was 0,38±0,08. Graft rejection has not been recorded. Emmetropia has been recorded in 7 eyes, hypermetropia – in 2, myopia – in 3; astigmatism >3D – in one eye.

Conclusions:

Rotational autokeratoplasty is an effective and safe alternative to other keratoplasty techniques in selected cases which makes possible to eliminate the risk of graft rejection and prolonged attrition of endothelial cell number that occurs following penetrating keratoplasty.

Financial Disclosure:

NONE

Back to previous